Frances M. Jagla

Shareholder | Seattle | 206.223.7749 |

Areas of Practice

Fran Jagla focuses her practice on trademark, copyright, Internet domain name matters and unfair competition counseling. She has extensive U.S. and international experience in name development, clearance filing, registration, maintenance and enforcement of trademarks and copyrights for Fortune 100 companies as well as startups and emerging companies. Fran possesses in-depth knowledge of trademark-related acquisitions, divestitures, licensing, Internet domain name matters and regulatory issues relating to healthcare and other regulated industry trademarks. World Trademark Review 1000 listed Fran as a top individual in the trademark practice, describing her as a “skilled, proactive and resourceful” adviser who is a “powerhouse — especially in the pharmaceutical trademarks domain — and an utter delight to work with” and that her “celebrated non-contentious skills are put to good use on trademark, labeling and domain name assignments for pharmaceutical manufacturer such as Endocyte, Incyte and Upsher-Smith Laboratories.” She is also an experienced project manager with a Yellow Belt certification in Legal Lean Sigma® and Project Management.

Professional Experience

  • Leydig, Voit & Mayer Ltd., Counsel (2008-2012)
  • Law Office of Frances M. Jagla, PLLC (2007-2008)
  • Microsoft Corporation, Senior Attorney – Trademarks (2004-2007)
  • Abbott Laboratories, Senior Counsel (1989-2004)
  • Miles, Inc., Attorney (1984-1989)

Admitted to Practice

  • Washington
  • U.S. District Court, Western District of Washington
  • U.S. District Court, Northern District of Indiana
  • Illinois (inactive)
  • Indiana (inactive)

Academics and Accreditations

  • Valparaiso University School of Law (J.D., 1984)
  • Indiana University (B.A., Political Science, 1981)
  • Legal Lean Sigma® and Project Management — Yellow Belt Certification

Practice Group and Specialty Team Memberships

  • Canada Practice
  • Cannabis
  • Food, Beverage and Hospitality
  • Intellectual Property and Technology
  • Startups and Emerging Companies

Representative Matters and Clients

  • Acquisition of Knoll AG
  • Spin-off of Abbott Laboratories’ Hospital Products Division into Hospira
  • Divestiture of Abbott Laboratories Animal Health and Agriculture Divisions
  • Negotiations with the United States Adopted Names Council and the World Health Organization for adoption of preferred non-proprietary names (USAN and INN)
  • Negotiations with FDA and EMEA for approval of preferred trademarks for pharmaceutical products


  • “Cannabis Marks in Jeopardy — Is Your Industry Next?” World Trademark Review, Co-author (January 2017)
  • “Profile: Fran Jagla,” Pharmaceutical Trade Marks Group’s Law Lore & Practice, Quoted (December 2016)
  • “Intellectual Property: Should You File Trademark Applications On Your Own?” Seattle Business magazine, Co-author (October 2015)
  • “New Canadian Pharmaceutical Naming Process in Effect,” Lane Powell Legal Update (June 16, 2015)
  • POM Wonderful: The New Prescription for False Advertising,” World Trademark Review’s “Pharmaceutical Trademarks 2015/2016 Global Guide” (February 2015)
  • “US Patent and Trademark Office Lowers Filing Fees for Trademark Applications and Renewals in 2015,” Lane Powell Legal Update, Co-author (January 29, 2015)
  • “A Rose by Any Other Name … Strategic Considerations While Selecting a Name for Your Company and Products,” Puget Sound Business Journal Startups and Emerging Companies: Kick-start Your New Year Special Insert (October 31, 2014)
  • “Trademark and Brand Name Issues for Drug and Medical Device Clients,” Inside the Minds: Navigating Drug and Medical Device Legal Issues, Aspatore Books (2014)
  • “Naming the Product:  The Intersection of the FDA and Trademark Law,” IP Litigator, Co-author (January/February 2009)
  • “Impact of Madrid Protocol on U.S. Practitioners:  An In-House Perspective,” International Trademark Association publication, Co-author (2003)

Speaking Engagements

  • “Securing Rights in Intangible Property Through Trademark, Copyrights, Patents and Trade Secrets” and “Trademark License Agreements — Can You Have an Alcoholic Beverage Brand Without a License?” National Business Institute Winery and Vineyard Law Seminar (December 5, 2016)
  • “From ‘No Way’ to ‘Here’s How’,” Law Seminars International’s Technology Law Conference, Moderator (December 1, 2016)
  • “Protection of Private Label Trademarks,” In-house CLE, Presenter (October 24, 2016)
  • “Hands off! Protecting Your Intellectual Property,” University of Washington School of Law’s Hospitality and Travel Law Symposium (April 15, 2016)
  • “As the World Turns — International Trademark Developments,” International Trademark Association’s Roundtable Discussion, Moderator (April 8, 2016)
  • “Naming Matters,” Lane Powell’s Second Annual Startups and Emerging Companies Seminar, Co-presenter, Seattle (December 2, 2015)
  • “Trademark Issues in Regulated Industries,” International Trademark Association/Office for Harmonization in the Internal Market Industry Seminar, Moderator (October 5, 2015)
  • “Mad About Madrid: New Strategies for International Trademarks,” Managing Intellectual Property Webinar (September 24, 2015)
  • “Managing Global Enforcement Matters,” International Trademark Association’s Roundtable Discussion, Moderator (February 17, 2015)
  • “Your Identity: Getting It Right From the Start,” Lane Powell’s First Annual Startups and Emerging Companies Seminar, Co-presenter, Seattle (December 4, 2014)
  • “Using Madrid Protocol — Risks and Rewards,” International Trademark Association’s 136th Annual Meeting, Panelist (May 13, 2014)
  • “Trademark Year in Review,” Washington State Bar Association’s 19th Annual Intellectual Property Institute (March 21, 2014)
  • “Trademarks in Regulated Industries, Such as Alcohol, Tobacco, Pharmaceuticals and Eco Marks,” International Trademark Association’s Roundtable Discussion, Moderator (April 18, 2013)
  • “Plugging the Leaky Pipeline: Promoting Women’s Leadership in Our Legal Community,” Washington Women Lawyer’s Town Hall Discussion, Panelist (February 27, 2013)
  • “The Role of the Attorney in the Use of the Madrid System in the United States,” Instituto Mexicano de la Propiedad Industrial Seminar (February 19, 2013)
  • “The Madrid Protocol and the Community Trademark,” International Trademark Association Roundtable (October 24, 2012)
  • “gTLDs:  Status, Process and How is It Working?” International Trademark Association Roundtable Discussion (April 10, 2012)
  • “Building the Bridge Between Legal and Marketing,” International Trademark Association’s 2010 Annual Meeting, Moderator (May 25, 2010)
  • “Policing Trademarks on the Internet and Web 2.0,” International Trademark Association Roundtable (January 19, 2010)
  • “Trademarks and the Internet — Three Things You Should Know,” Center for American and International Law Annual IP Meeting (November 10-11, 2008)
  • “FDA Bootcamp-Naming the Product:  The Intersection of FDA and Trademark Law,” American Intellectual Property Law Association Annual Meeting (October 23-25, 2008)
  • “The Future of Pharmaceutical Trademarks,” Pharmaceutical Trade Marks Group Autumn Meeting (October 1-4, 2008)
  • “Strategies for the International Protection of Intellectual Property,” Inside Counsel Super Conference (2007)
  • “Adherence to Madrid Protocol and Protection for Famous Names,” USPTO/ASEAN Trademark Office Officials Meeting/Bangkok (2006)
  • “International Trademark Enforcement and Filing Strategies,” International Trademark Association’s Meeting China Trademark Owners (2005)
  • “United States Food and Drug Administration and European EMEA — Pharmaceutical Trademarks,” Pharmaceutical Trade Marks Group Annual Meeting (2004)

Awards and Honors

  • Named a “Leading Trademark Professional” by World Trademark Review 1000 (2014-2017)
  • Named as a “Washington Super Lawyer,” Super Lawyers® magazine, Intellectual Property (2016-2017)
  • Paul A. Welter 1st Annual Award for Excellence in Trademark Law, Merchant & Gould/William Mitchell School of Law (2007)
  • Microsoft Corporate Marketing Group’s Most Valued Partner (2006-2007)

Professional and Community Activities

  • Board of Trustees, MedERRS, Institute for Safe Medication Practices (2005-Present)
  • International Trademark Association (INTA)
    • Co-chair, Government Officials and Education Training Committee, Office of Harmonization in the Internal Market’s Industry Training Seminars Subcommittee (2014-2015)
    •  Bulletins Committee (2010-2013)
    •     Board of Directors (2005-2007)
    •     Subcommittee Chair, Madrid Protocol (2004)
    •     Board of Directors, Executive Committee, Secretary (1995-1997)
    •     Annual Meeting Chair (1997)
  • Pharmaceutical Trade Marks Group (PTMG)
    •     Board of Directors (2004)
  • Member, Washington State Bar Association
  • Member, Indiana University Alumni Association

Frances M. Jagla

Shareholder | Seattle | 206.223.7749 |